$FEED Cashflow Statement | Understand Stock

$FEED

$1.03 +$0.00 (0.0%) Close

$FEED Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to Net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Arbitration settlement expense
Warrant modification expense
Change in fair value of equity investment
Change in fair value of derivative liabilities
Gain on purchase of warrants
Gain/Loss on termination of investment
Noncash interest expense
Other
Changes in deferred income taxes, net
Change in fair value of warrant liability
Goodwill impairment charge
Issuance cost allocated to warrant liability

Changes in operating assets and liabilities:
Trade receivable
Other accounts receivable and prepaid expenses
Prepaid expenses and other accounts receivable
Inventory
Trade payables
Other accounts payable and accrued expenses
Deferred revenue
Operating right of use asset
Operating lease liabilities
Accrued severance pay, net
Net cash used in operating activities
Cash flows from investing activities:
Cash acquired in Envue Merger
Purchase of property plant and equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from sale of common stock, net
Proceeds from the issuance of common stock, preferred stock and warrants, net
Repurchase of Series X Preferred Stock
Proceeds from issuance of notes payable to related party
Payments of note payable to related party
Payments of short-term loan to related party
Proceeds from issuance of short-term loan payable
Proceeds from exercise of warrants
Proceeds from exercise of prefunded warrants
Buy back of warrants from investor
Other
Net cash provided by financing activities

Effects of currency translation on cash and cash equivalents
Net increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash at end of period
Total cash, cash equivalents and restricted cash
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for taxes
Non-cash transactions:
Exchange of common stock into preferred stock
Shares issued from exercise of warrants previously classified as derivative liability
Reclass derivative liability to equity due to increase in authorized shares
Reclass liability to equity after increase in authorized shares
Right of use asset obtained in the exchange for operating lease liabilities

Comments